Y-Biologics, Inc.

₩7,360As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:338840Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (23.13%)
Div yield —
ROE (297.87%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.10
PE TTM —
TSR TTM (67.79%)
Mkt cap ₩113.1B
ROIC (32.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,815
19.78%
(62.45%)
Buy 3|0|1|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
100.30
96.00
94.87
105.95
(3.17%)
(3.50%)
(7.22%)
5.35%
Revenue₩B
5.223
5.503
5.808
5.982
9.79%
10.47%
10.15%
16.34%
Peers (US$83.39M)
Cap (US$)
PE
88.81M
—
88.47M
132.0x
84.89M
—
Capital
TTM
5Y
10Y
Leveragex
1.780
(0.131)
(0.104)
EBIT/Intx
1.086
0.050
0.077
Own earn%
52.45
(18.98)
(19.75)
Sh yield%
32.46
2.76
2.31
Owners
Insiders/Inst%
8.33
68.18
Short interest%
5.42
SBC / revenue%
4.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
26–35
$1 testx
0.0
Incr. ROIC%
1